Cargando…

DNA methylation changes in CD4(+) T cells isolated from multiple sclerosis patients on dimethyl fumarate

BACKGROUND: Dimethyl fumarate is an oral treatment for multiple sclerosis, whose mechanism of action is not fully understood. OBJECTIVE: To investigate the effects of dimethyl fumarate on DNA methylation in the CD4(+) T cells of multiple sclerosis patients. METHODS: We performed Illumina EPIC arrays...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maltby, Vicki E, Lea, Rodney A, Ribbons, Karen A, Sanders, Katherine A, Kennedy, Daniel, Min, Myintzu, Scott, Rodney J, Lechner-Scott, Jeannette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050818/ https://www.ncbi.nlm.nih.gov/pubmed/30038789 http://dx.doi.org/10.1177/2055217318787826

Ejemplares similares

Genome-wide DNA methylation profiling of CD8+ T cells shows a distinct epigenetic signature to CD4+ T cells in multiple sclerosis patients
por: Maltby, Vicki E., et al.
Publicado: (2015)

Differential methylation at MHC in CD4(+) T cells is associated with multiple sclerosis independently of HLA-DRB1
por: Maltby, Vicki E., et al.
Publicado: (2017)

The effect of cladribine on immunoglobulin levels compared to B cell targeting therapies in multiple sclerosis
por: Lycett, Mitchell J, et al.
Publicado: (2023)

Genome-wide DNA methylation changes in CD19(+) B cells from relapsing-remitting multiple sclerosis patients
por: Maltby, Vicki E., et al.
Publicado: (2018)

Letter to the editor: blood processing and sample storage have negligible effects on methylation
por: Groen, Kira, et al.
Publicado: (2018)

Erythrocytes in multiple sclerosis – forgotten contributors to the pathophysiology?
por: Groen, Kira, et al.
Publicado: (2016)

Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis
por: Groen, Kira, et al.
Publicado: (2018)

Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+ T cells
por: Sanders, Katherine A., et al.
Publicado: (2016)

Whole-blood methylation signatures are associated with and accurately classify multiple sclerosis disease severity
por: Campagna, Maria Pia, et al.
Publicado: (2022)

2D in-vivo L-COSY spectroscopy identifies neurometabolite alterations in treated multiple sclerosis
por: Quadrelli, Scott, et al.
Publicado: (2019)

Erythrocyte microRNAs show biomarker potential and implicate multiple sclerosis susceptibility genes
por: Groen, Kira, et al.
Publicado: (2020)

Parity is associated with long-term differences in DNA methylation at genes related to neural plasticity in multiple sclerosis
por: Campagna, Maria Pia, et al.
Publicado: (2023)

Increased DNA methylation of SLFN12 in CD4(+) and CD8(+) T cells from multiple sclerosis patients
por: Rhead, Brooke, et al.
Publicado: (2018)

Epigenetic differences at the HTR2A locus in progressive multiple sclerosis patients
por: Maltby, Vicki E., et al.
Publicado: (2020)

Can a stress management programme reduce stress and improve quality of life in people diagnosed with multiple sclerosis?
por: Agland, Susan, et al.
Publicado: (2018)

Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis
por: Xavier, Alexandre, et al.
Publicado: (2023)

Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate
por: Spencer, Collin M., et al.
Publicado: (2015)

Fast magnetic resonance spectroscopic imaging techniques in human brain- applications in multiple sclerosis
por: Al-iedani, Oun, et al.
Publicado: (2017)

A comparison between the pathophysiology of multiple sclerosis and normal pressure hydrocephalus: is pulse wave encephalopathy a component of MS?
por: Bateman, Grant A., et al.
Publicado: (2016)

Capturing SNP Association across the NK Receptor and HLA Gene Regions in Multiple Sclerosis by Targeted Penalised Regression Models
por: Burnard, Sean M., et al.
Publicado: (2021)

DNA Methylation Signatures of Multiple Sclerosis Occur Independently of Known Genetic Risk and Are Primarily Attributed to B Cells and Monocytes
por: Xavier, Alexandre, et al.
Publicado: (2023)

Epigenome-wide association studies: current knowledge, strategies and recommendations
por: Campagna, Maria Pia, et al.
Publicado: (2021)

Evaluation of Cell-Specific Epigenetic Age Acceleration in People With Multiple Sclerosis
por: Maltby, Vicki, et al.
Publicado: (2023)

Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study)
por: Maltby, Vicki E, et al.
Publicado: (2021)

Advances in the management of relapsing–remitting multiple sclerosis: role of oral dimethyl fumarate (BG-12)
por: Nielsen, A Scott
Publicado: (2015)

Disseminated zoster with paresis in a multiple sclerosis patient treated with dimethyl fumarate
por: Ma, Brandy B., et al.
Publicado: (2016)

Delayed-release dimethyl fumarate and disability assessed by the Multiple Sclerosis Functional Composite: Integrated analysis of DEFINE and CONFIRM
por: Giovannoni, Gavin, et al.
Publicado: (2016)

Effectiveness and safety of dimethyl fumarate in progressive multiple sclerosis
por: Moreira Ferreira, Vanessa F, et al.
Publicado: (2021)

Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple Sclerosis
por: Mills, Elizabeth A., et al.
Publicado: (2018)

Dimethyl fumarate mitigates optic neuritis
por: Zyla, Katarzyna, et al.
Publicado: (2019)

Effect of dimethyl fumarate on lymphocyte subsets in patients with relapsing multiple sclerosis
por: Buckle, Guy, et al.
Publicado: (2020)

Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis
por: Laplaud, David-Axel, et al.
Publicado: (2019)

Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment
por: Vollmer, Brandi L., et al.
Publicado: (2018)

COVID‐19 in dimethyl fumarate‐treated patients with multiple sclerosis
por: Mantero, Vittorio, et al.
Publicado: (2020)

COVID-19 in multiple sclerosis patients treated with dimethyl fumarate
por: Capone, Fioravante, et al.
Publicado: (2021)

Genetic Study of Severe Prolonged Lymphopenia in Multiple Sclerosis Patients Treated With Dimethyl Fumarate
por: Sangurdekar, Dipen, et al.
Publicado: (2019)

Dimethyl Fumarate Reduces Inflammation in Chronic Active Multiple Sclerosis Lesions
por: Zinger, Nicole, et al.
Publicado: (2022)

Progressive multifocal leukoencephalopathy outcomes in patients with multiple sclerosis treated with dimethyl fumarate
por: Lyons, Jennifer, et al.
Publicado: (2022)

IL-17(+) CD8(+) T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis
por: Lückel, Christina, et al.
Publicado: (2019)

Lymphocyte subtypes in relapsing–remitting multiple sclerosis patients treated with dimethyl fumarate
por: Chaves, C, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9v9hsprdnu3mtoaltbiq7d6089